Please rate:

(TISI, KALU, SOMX) CRWENewswire Stocks to Watch

Somaxon Pharmaceuticals Incorporated - symbol SOMX - reported that it recently had a meeting with the FDA, who provided clinical and regulatory guidance relating to the over-the-counter development program for Silenor. Somaxon believes that Silenor’s characteristics, including its lack of addiction potential and its clinical efficacy and safety profile, make it an ideal candidate to be the first prescription insomnia product to be converted to an OTC product



Previous Media Next Media
Show Description Hide Description

Recommended




 
Visit Disclose.tv on Facebook